What is CJC-1295?
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It is studied in two forms: "no DAC" (also called Mod GRF 1-29), which is short-acting, and "with DAC" (Drug Affinity Complex), which binds albumin for a markedly longer half-life in research models.
How is CJC-1295 studied in equine research?
In equine veterinary research, CJC-1295 is studied as a model compound for growth-hormone release research. The horse is one of the most-studied large-animal models in connective-tissue and musculoskeletal research because equine tendon and ligament injuries are common and slow to resolve. Peptides associated with angiogenesis and tissue repair, such as BPC-157 and TB-500 (Thymosin Beta-4), appear frequently in equine-model research literature for exactly this reason.
CJC-1295 research focuses on stimulation of the pituitary to release growth hormone in pulses. The DAC version extends the active window, while the no-DAC version produces a sharper, shorter pulse often studied alongside a GHRP such as Ipamorelin for synergistic release.
Sourcing, purity & COA for Horses CJC-1295 research
Every lot supplied for Horses CJC-1295 research is third-party tested to a 99%+ purity target, with identity confirmed by mass spectrometry and purity quantified by HPLC. A Certificate of Analysis is available on request and ties each vial to a tracked lot. We ship nationwide to veterinary and university research programs with cold-chain handling where appropriate. Publicly verifiable third-party documentation is the trust standard for serious veterinary research material.
Frequently asked questions
Is CJC-1295 studied in equine research?
CJC-1295 appears in equine research models as a model compound (A GHRH analog studied for growth-hormone-release research, with and without DAC.). It is research-use-only and not for administration to horses. CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). CJC-1295 research focuses on stimulation of the pituitary to release growth hormone in pulses. The DAC version extends the active window, while the no-DAC version produces a sharper, shorter pulse often studied alongside a GHRP such as Ipamorelin for synergistic release.
Is CJC-1295 approved for horses?
No. CJC-1295 is not approved by the FDA for veterinary use and is supplied strictly for laboratory and veterinary research, not for administration to any animal. All material is research-use-only, is not for administration to horses or any other animal, is not for food-producing animals, and is not veterinary medical advice.
What sizes of CJC-1295 are available?
CJC-1295 ships as lyophilized research vials (2 mg vial, 5 mg vial), third-party tested with a COA on request. CJC-1295 is supplied as a lyophilized (freeze-dried) powder in 2 mg and 5 mg research sizes. Material ships nationwide to qualified research programs in all 50 US states as stable lyophilized vials, with cold-chain handling where appropriate.
Can veterinary researchers order CJC-1295 B2B?
Yes - we supply qualified veterinary researchers and facilities B2B and via the research portal. Every lot is third-party tested to a 99%+ purity target, with identity confirmed by mass spectrometry and purity quantified by HPLC, and a Certificate of Analysis is available on request.
How is CJC-1295 purity verified for equine research?
Purity is verified by an independent third-party laboratory: HPLC quantifies purity against a 99%+ target and mass spectrometry confirms identity. The resulting Certificate of Analysis is tied to the tracked lot of the vial you receive and is available on request, so equine study records stay traceable.
How is CJC-1295 stored for research?
Un-reconstituted CJC-1295 vials are stored refrigerated and protected from light; the lyophilized powder is stable enough to tolerate shipping. After reconstitution to a defined concentration, research solutions are kept at 2-8C, away from light, and used within roughly two to four weeks, labeled with concentration and date.
All horses research peptides · CJC-1295 overview
External references: FDA Center for Veterinary Medicine · Peptide (Wikipedia)